Skip to main content

Grafa News and Videos — Page 1413

Latest

Grafa

Adagio Medical reports strong FULCRUM-VT trial data for vCLAS Ablation System

Adagio Medical Holdings (NASDAQ:ADGM) unveiled positive six-month results from its FULCRUM-VT clinical trial on Monday, providing the foundational data required for its forthcoming Food and Drug Administration (FDA) Premarket Approval application.

Read more: Adagio Medical reports strong FULCRUM-VT trial data for vCLAS Ablation System

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift